Hangzhou Biotest Biotech Co., Ltd. – a National High-tech Enterprise, is a professional manufacturer specializing in medical in vitro diagnostic assays and reagents, instrumentresearch and development, and world-class sales and service. Biotest was established in 2008 with headquarters located in the natural scenic Eco-Industrial Park Yuhang District of Hangzhou city. Our flagship facility consists of an area of 25,000 square meters with registered capital of 80 million RMB.


Hangzhou Biotest Biotech Co., Ltd. supplies major IVD categories: women’s health, drug testing/toxicology, infectious disease identification, tumor marker detection and cardiac marker monitoring.  Biotest harnesses the world-leading technologies of bioengineering by using gene recombinant antigens, synthetic antigens, mono-specific antibodies and polyclonal antibodies combined with latex and colloidal metal particles on immuno-chromatographic assay scaffold to accomplish our test development goals.


Biotest’s mission is to “provide customers with accurate, convenient and affordable medical test products.” Our elite employees possess the talent and prowess to drive the accelerated yet sustainable development of our enterprises.  Over the years, Biotest has been steadfast in adhering to the principle of fostering healthy lives and is committed to funding the constant innovation required to continue our goal of overall wellness for mankind.


In 2015, Biotest embarked on the new journey of strategic global deployment by acquiring the American company Advin Biotech, Incorporated. This event marked our resolve towards penetrating the highly coveted American market. Advin Biotech is FDA registered and specializes in toxicology products including single drug combination and multiple drug combination detection kits. The company provides the most comprehensive drug detection tests for the American and global drug-testing markets including employee screening, medical diagnostics, judicial compliance and military testing.


     About Us